ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,806, issued on June 10, was assigned to PHARMA MAR S.A. (Madrid).
"Method of treating SCLC and managing hepatotoxicity" was invented by Carmen Kahatt (Madrid), Jose Maria Fernandez (Madrid), Salvador Fudio (Madrid), Arturo Soto (Madrid), Pilar Lardelli (Madrid) and Cristian Fernandez (Madrid).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further ...